¼¼°èÀÇ Á¶¿µÁ¦ ÀÎÁ§ÅÍ ½ÃÀå
Contrast Injectors
»óǰÄÚµå : 1528033
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 194 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¶¿µÁ¦ ÀÎÁ§ÅÍ ½ÃÀåÀº 2030³â±îÁö 11¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

2023³â¿¡ 8¾ï 3,050¸¸ ´Þ·¯·Î ÃßÁ¤µÈ Á¶¿µÁ¦ ÀÎÁ§ÅÍ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.6%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 11¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÎÁ§ÅÍ ¼Ò¸ðǰÀº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.3%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½Ã 4¾ï 7,080¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÎÁ§ÅÍ ½Ã½ºÅÛ ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 5.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 2¾ï 2,400¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¹Ì±¹ Á¶¿µÁ¦ ÀÎÁ§ÅÍ ½ÃÀåÀº 2023³â 2¾ï 2,400¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ¿¹Ãø ±â°£ µ¿¾È º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 7.7%·Î ¼ºÀåÀ» Áö¼ÓÇÏ¿© 2030³â¿¡´Â 2¾ï 4,160¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)Àº °¢°¢ 1.4%¿Í 5.1%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 2.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°è Á¶¿µÁ¦ ÀÎÁ§ÅÍ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à

Á¶¿µÁ¦ ÀÎÁ§ÅͶõ ¹«¾ùÀΰ¡, ÀÇ·á È­»ó¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿À´Â °ÍÀΰ¡?

Á¶¿µÁ¦ ÀÎÁ§ÅÍ´Â ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ(CT), ÀÚ±â°ø¸í¿µ»ó¹ý(MRI), Ç÷°üÁ¶¿µ µî ÀÇ·á ¿µ»ó Áø´Ü ±â¼ú¿¡¼­ Á¶Á÷, Àå±â, Ç÷°üÀÇ °¡½Ã¼ºÀ» ³ôÀ̱â À§ÇØ Á¶¿µÁ¦¸¦ ü³»¿¡ ÁÖÀÔÇϱ⠶§¹®¿¡ ¿¡ »ç¿ëµÇ´Â Ư¼ö ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÀåÄ¡´Â °íǰÁú Áø´Ü À̹ÌÁö¸¦ ¾ò±â À§ÇØ Áß¿äÇÑ ÃÔ¿µ °úÁ¤¿¡¼­ Á¶¿µÁ¦°¡ ±ÕÀÏÇϰí Á¤È®ÇÏ°Ô ºÐÆ÷µÇµµ·Ï º¸ÀåÇÕ´Ï´Ù. Á¶¿µÁ¦ ÀÎÁ§ÅÍ´Â Áø´ÜÀÇ Á¤È®¼ºÀ» Çâ»ó½Ãų»Ó¸¸ ¾Æ´Ï¶ó Á¶¿µÁ¦ÀÇ Åõ¿© ·®°ú Åõ¿© ¼Óµµ¸¦ Á¦¾îÇÔÀ¸·Î½á ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ƯÈ÷ Á¶¿µÁ¦ÀÇ Åõ¿© ¼Óµµ°¡ ³Ê¹« ºü¸£°Å³ª ³Ê¹« ¸¹Àº ¿ë·®ÀÌ ÀÖÀ» °æ¿ì ¼öµ¿ ÁÖ»ç·Î ¹ß»ýÇÒ ¼ö ÀÖ´Â Á¶¿µÁ¦ ½ÅÁõ°ú °°Àº ÇÕº´ÁõÀ» ¿¹¹æÇÏ´Â µ¥ Áß¿äÇÕ´Ï´Ù.

Á¶¿µÁ¦ ÀÎÁ§ÅÍ´Â ¾î¶»°Ô Áø´ÜÀÇ Á¤È®µµ¿Í ȯÀÚÀÇ ¾ÈÀü¼ºÀ» ³ôÀ̴°¡?

Á¶¿µÁ¦ ÀÎÁ§ÅͰ¡ Á¦°øÇÏ´Â Á¤È®µµ¿Í ÄÁÆ®·ÑÀ» ÅëÇØ ¹æ»ç¼± ±â¼úÀÚ´Â º¸´Ù ¼±¸íÇÏ°í »ó¼¼ÇÑ À̹ÌÁö¸¦ ¾òÀ» ¼ö ÀÖ¾î Áø´Ü Á¤È®µµ°¡ Å©°Ô Çâ»óµË´Ï´Ù. ÀÌ ÀåÄ¡¿¡´Â °í±Þ ¼ÒÇÁÆ®¿þ¾î°¡ žÀçµÇ¾î ÀÖÀ¸¸ç °¢ ½ºÄµ ¹× ȯÀÚ À¯Çü¿¡ µû¶ó Á¶¿µÁ¦ÀÇ À¯·®°ú ¾çÀ» Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ¸ÂÃãÇü Á¢±Ù¹ýÀº ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÃÖ¼ÒÈ­Çϰí Á¶¿µÁ¦¸¦ È¿À²ÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÃֽŠÁ¶¿µÁ¦ ÀÎÁ§ÅÍ¿¡´Â Á¶¿µÁ¦ ÁÖÀÔ ½Ã ÀáÀçÀûÀÎ À§ÇèÀÎ °ø±â »öÀüÁõ°ú Ç÷°ü¿Ü ħÀ±À» ¹æÁöÇϱâ À§ÇÑ °ø±â °¨Áö±â ¹× ¾Ð·Â ¼¾¼­¿Í °°Àº ¾ÈÀü ±â´ÉÀÌ ÅëÇյǾî ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â ȯÀÚÀÇ ¾ÈÀü°ú Æí¾ÈÇÔÀ» Å©°Ô Çâ»ó½Ã۰í Áø´Ü ÀýÂ÷ÀÇ Àü¹ÝÀûÀÎ È¿°ú¸¦ Çâ»ó½Ãŵ´Ï´Ù.

Á¶¿µÁ¦ ÀÎÁ§ÅÍÀÇ Àå·¡¸¦ Çü¼ºÇÏ´Â ±â¼úÀû Áøº¸¶õ?

Á¶¿µÁ¦ ÁÖÀÔ ½Ã½ºÅÛÀÇ ÃÖ±Ù ±â¼úÀû Áøº¸´Â ¿¬°á¼º, »ç¿ë ÆíÀǼº, ÀÚµ¿È­ °­È­¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ¸¹Àº ÃֽŠÀÎÁ§ÅÍ´Â ÅÍÄ¡½ºÅ©¸° ÀÎÅÍÆäÀ̽º¿Í »çÀü ÇÁ·Î±×·¡¹ÖµÈ ÇÁ·ÎÅäÄÝÀ» ÀåÂøÇÏ¿© Á¶ÀÛÀ» ´Ü¼øÈ­Çϰí ÈÞ¸Õ ¿À·ùÀÇ °¡´É¼ºÀ» ÁÙÀÔ´Ï´Ù. ¹«¼± ÀÎÅÍÆäÀ̽º¿Í °°Àº ¿¬°á¼º Çâ»óÀ» ÅëÇØ ÀÌ·¯ÇÑ Àåºñ´Â º´¿ø Á¤º¸ ½Ã½ºÅÛ(HIS) ¹× À̹ÌÁö º¸Á¸ Åë½Å ½Ã½ºÅÛ(PACS)°ú ¿øÈ°ÇÏ°Ô ÅëÇÕµÉ ¼ö ÀÖ¾î µ¥ÀÌÅÍ °ü¸® ¹× ¿öÅ©Ç÷οì È¿À²¼º Çâ»óÀ» ÃËÁøÇÕ´Ï´Ù. ¶ÇÇÑ ÀϺΠ¼±Áø±âÁ¾¿¡´Â ¼±·®°ü¸® ¼ÒÇÁÆ®¿þ¾î°¡ žÀçµÇ¾î ÀÖ¾î Á¶¿µÁ¦ÀÇ »ç¿ë·®À» ÃßÀû,°ü¸®ÇÒ ¼ö ÀÖÀ¸¹Ç·Î ¹æ»ç¼±¾ÈÀü±âÁØÀ» ÁؼöÇÏ°í Æó±â¹°À» ÃÖ¼ÒÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº Á¶¿µÁ¦ ÀÎÁ§ÅÍÀÇ ±â´ÉÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó º¸´Ù Áö¼Ó°¡´ÉÇÏ°í ºñ¿ë È¿À²ÀûÀÎ °Ç°­ °ü¸®¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº?

Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡, À̹Ì¡ ±â¼úÀÇ Áøº¸, Á¶±â ¹× Á¤È®ÇÑ Áø´Ü ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ¾ß±âµË´Ï´Ù. ½ÉÇ÷°üÁúȯ, ¾Ï, ½Å°æÁúȯ µîÀÇ ¸¸¼ºÁúȯÀÌ ÀϹÝÀûÀÌ µÊ¿¡ µû¶ó ÀÌ·¯ÇÑ ÁúȯÀ» °ËÃâ,°¨½ÃÇϱâ À§ÇÑ °íµµÀÇ Áø´Ü Åø¿¡ ´ëÇÑ ¿ä±¸µµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ Á¡¿¡¼­ Á¶¿µÁ¦ ÀÎÁ§ÅÍ´Â Á¤È®ÇÑ Áø´Ü°ú Ä¡·á °èȹ¿¡ ÇʼöÀûÀÎ ¿µ»ó Áø´ÜÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â Áß¿äÇÑ ¿ªÇÒÀ» ´ã´çÇÕ´Ï´Ù. °Ô´Ù°¡, º¸´Ù ¾ÈÀüÇϰí, º¸´Ù È¿À²ÀûÀ̸ç, »ç¿ëÀÚ Ä£È­ÀûÀÎ ÁÖ»ç±â·Î À̾îÁö´Â ±â¼ú Çõ½ÅÀÌ ÁøÇàµÇ°í Àֱ⠶§¹®¿¡ ÀÌ·¯ÇÑ Àåºñ´Â Ãֽйæ»ç¼±°ú¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ¸¶Áö¸·À¸·Î ¼¼°è °Ç°­ ÀÎÇÁ¶óÀÇ È®´ë¿Í °³¹ß µµ»ó±¹ÀÇ ÀÇ·áºñ Áõ°¡´Â Á¶¿µÁ¦ ÀÎÁ§Å͸¦ Æ÷ÇÔÇÑ Áøº¸ µÈ Áø´Ü ÀåºñÀÇ ±¤¹üÀ§ÇÑ µµÀÔ¿¡ ±â¿©ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ °áÇյǾî Á¶¿µÁ¦ ÁÖÀԱ⠽ÃÀåÀÇ Áö¼ÓÀûÀÎ °³Ã´°ú È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖÀ¸¸ç Çö´ë ÀÇ·á ÇöÀå¿¡¼­ Á¶¿µÁ¦ ÁÖÀÔ±âÀÇ Á߿伺À» ¹Ý¿µÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(Àü 41°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Contrast Injectors Market to Reach US$1.1 Billion by 2030

The global market for Contrast Injectors estimated at US$830.5 Million in the year 2023, is expected to reach US$1.1 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Injector Consumables, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$470.8 Million by the end of the analysis period. Growth in the Injector Systems segment is estimated at 5.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$224.0 Million While China is Forecast to Grow at 7.7% CAGR

The Contrast Injectors market in the U.S. is estimated at US$224.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$241.6 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.4% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global Contrast Injectors Market - Key Trends and Drivers Summarized

What Are Contrast Injectors and How Are They Revolutionizing Medical Imaging?

Contrast injectors are specialized medical devices used to inject contrast agents into the body to enhance the visibility of tissues, organs, and blood vessels in medical imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and angiography. These devices ensure that the contrast agent is distributed evenly and precisely during the imaging process, which is critical for producing high-quality diagnostic images. Contrast injectors not only improve the accuracy of diagnoses but also increase the safety for patients by controlling the dose and rate of contrast agent administered. This is particularly important to prevent complications such as contrast-induced nephropathy, which can occur with manual injections if the contrast is administered too quickly or in too high a dose.

How Do Contrast Injectors Enhance Diagnostic Precision and Patient Safety?

The precision and control offered by contrast injectors allow radiologists to obtain clearer and more detailed images, significantly enhancing diagnostic accuracy. These devices are equipped with sophisticated software that can adjust the flow rate and volume of contrast medium according to the specific requirements of each scan and patient type. This tailored approach helps in minimizing the risk of adverse reactions and ensures that the contrast agent is utilized efficiently. Furthermore, modern contrast injectors are integrated with safety features such as air detectors and pressure sensors that help prevent air embolism and extravasation—two potential risks during contrast media injection. These advancements significantly enhance patient safety and comfort, thereby improving the overall efficacy of diagnostic procedures.

What Technological Advancements Are Shaping the Future of Contrast Injectors?

Recent technological advancements in contrast injector systems are focused on enhancing connectivity, user-friendliness, and automation. Many modern injectors are now equipped with touch-screen interfaces and pre-programmed protocols, which simplify the operation and reduce the possibility of human error. Connectivity enhancements such as wireless interfaces allow these devices to integrate seamlessly with hospital information systems (HIS) and picture archiving and communication systems (PACS), facilitating better data management and workflow efficiency. Additionally, some advanced models feature dose management software that can track and control the amount of contrast used, helping to adhere to radiation safety standards and minimize waste. These innovations not only improve the functionality of contrast injectors but also contribute to more sustainable and cost-effective healthcare practices.

What Drives the Growth in the Contrast Injector Market?

The growth in the contrast injector market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in imaging technologies, and the rising demand for early and accurate diagnostic methods. As chronic conditions such as cardiovascular diseases, cancer, and neurological disorders become more common, the need for advanced diagnostic tools to detect and monitor these diseases also grows. Contrast injectors play a crucial role in this regard by enhancing the quality of imaging, which is essential for accurate diagnosis and treatment planning. Additionally, the ongoing technological innovations that lead to safer, more efficient, and user-friendly injectors are making these devices indispensable in modern radiology departments. Finally, the global expansion of healthcare infrastructure and increased healthcare spending in developing countries are contributing to the wider adoption of advanced diagnostic equipment, including contrast injectors. These factors collectively fuel the continuous development and expansion of the contrast injector market, reflecting its critical importance in contemporary medical practice.

Select Competitors (Total 41 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â